US Physical Therapy (USPH) Tops Q4 EPS by 8c, FY EPS Guidance About In-Line
Tweet
Share
E-mailGet Alerts USPH Hot Sheet
Price: $79.35 --0%
EPS Growth %: +16.7%
Financial Fact:
Net income attributable to common shareholders: 5.71M
Today's EPS Names:
BIOX, PMCB, PLCE, More
EPS Growth %: +16.7%
Financial Fact:
Net income attributable to common shareholders: 5.71M
Today's EPS Names:
BIOX, PMCB, PLCE, More
Join SI Premium – FREE
US Physical Therapy (NYSE: USPH) reported Q4 EPS of $0.71, $0.08 better than the analyst estimate of $0.63. Revenue for the quarter came in at $117.3 million versus the consensus estimate of $117.03 million.
GUIDANCE:
US Physical Therapy sees FY2019 EPS of $2.76-$2.85, versus the consensus of $2.80.
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- DBS Group Downgrades RoboSense Technology (2498:HK) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
